McDonnell Boehnen Hulbert & Berghoff LLP partner Dr. Kevin Noonan is quoted in a November 13, 2019 Law360.com article entitled, “Drug Cos. May Rethink Patent Strategy After Fed. Circ. Ruling.” A recent Federal Circuit ruling could reinvigorate certain types of challenges to pharmaceutical patents and force drugmakers to rethink the way they go about protecting some inventions, attorneys say. View the article
